Bernardo García-Carreras, etc.,al. [preprint]Assessing evidence of immune imprinting in serological patterns of influenza immune response. https://doi.org/10.1101/2025.10.28.25338971
The subtype of the first infiuenza infection shapes infection risk, illness and mortality associated with subsequent infection subtypes, as well as vaccine efficacy. This phenomenon, termed ‘immune imprinting’, may result from immune recognition rooted in structural similarity of the hemagglutinin protein within subtypes of infiuenza viruses. However, it is difficult to isolate from cohort effects resulting from the annual dominance of specific infiuenza subtypes. We used a long-term cohort study in southern China to examine whether hemagglutination inhibition responses show evidence of imprinting, and explore whether such patterns could emerge in the absence of imprinting using simulations. Our statistical analysis reveals patterns consistent with immune imprinting. However, simulations showed that similar patterns can emerge without an imprinting mechanism, meaning these may partly be due to age-related variations in immune responses driven by other factors. This work lays the foundations for further research into immune imprinting while accounting for cohort effects.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 4 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 4 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 4 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 4 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 4 hours ago
[Go Top] [Close Window]


